Pain Management Devices Monitoring - NCLEX-PN

Verify medication, concentration, route, and pump settings. Verification ensures correct drug delivery, preventing errors in dosing or route that could lead to under-treatment or life-threatening complications.

Pain score before and after dosing with functional improvement. Comparing pre- and post-dosing pain scores alongside functional status objectively measures analgesia efficacy and guides therapy adjustments.

Patient is alert, understands instructions, and can press the button. Alertness and comprehension ensure the patient can appropriately self-dose without risking overdose due to impaired judgment or inability to operate the device.

Respiratory depression or excessive sedation. These signs indicate potential opioid toxicity, warranting dose withholding and escalation to prevent progression to respiratory arrest or other severe outcomes.

Signs of overdose/withdrawal and pump/catheter malfunction. Intrathecal pumps deliver drugs directly to the spinal cord, requiring vigilance for dosage imbalances or device failures that could cause serious complications.

Diaphoresis with anxiety, abdominal cramps, and tachycardia. Abrupt cessation triggers sympathetic hyperactivity and gastrointestinal distress as classic manifestations of opioid withdrawal syndrome requiring prompt intervention.

Patient-controlled analgesia. PCA refers to a system allowing patients to self-administer pain relief medication within prescribed limits to manage acute pain effectively.

Baseline respiratory status (rate, depth, sedation level). Assessing baseline respiratory function is crucial as opioids can suppress breathing, establishing a reference for detecting adverse changes during therapy.

Respiratory depression. Opioids in PCA can suppress the respiratory drive, making it the most critical complication requiring vigilant monitoring to ensure patient safety.

Level of consciousness/sedation score. Trending sedation levels helps detect early opioid-induced central nervous system depression, allowing timely intervention to prevent respiratory compromise.

Stop and re-educate; only the patient must press the button. Family involvement in dosing can lead to overdose since only the patient experiences the pain and sedation feedback necessary for safe use.

Lockout interval. The lockout interval ensures a minimum time between doses, safeguarding against excessive opioid accumulation and associated risks like respiratory depression.

Continuous background opioid infusion. Basal rate provides a steady low-level opioid delivery to maintain consistent pain control, supplementing patient-initiated boluses in PCA therapy.

Obstructive sleep apnea. Obstructive sleep apnea predisposes patients to hypoxia and hypercapnia, exacerbating opioid-induced respiratory suppression during PCA use.

Stop opioid infusion and notify the provider/rapid response. Unarousable patients indicate severe sedation or overdose, necessitating immediate cessation of opioids and urgent medical intervention to reverse effects.

Naloxone. Naloxone reverses opioid effects by competitively binding to mu-receptors, rapidly restoring respiration in cases of PCA-induced overdose.

Respirations, blood pressure, and motor/sensory function. Epidural infusions can affect respiratory effort, cause vasodilation leading to hypotension, and impact nerve function, requiring comprehensive monitoring for complications.

Hypotension with increasing numbness/weakness and dyspnea. A high spinal block extends anesthesia cephalad, blocking sympathetic nerves and intercostal muscles, resulting in cardiovascular and respiratory instability.

Hypotension from sympathetic blockade. Local anesthetics in epidurals inhibit sympathetic outflow, causing vasodilation and reduced blood pressure, which must be monitored to prevent hemodynamic instability.

Leakage, redness, swelling, or signs of infection. Regular site checks detect complications like catheter dislodgement, inflammation, or infection early, ensuring safe continuation of epidural therapy.

Keep epidural line clearly labeled and dedicated (no IV connection). Clear labeling and separation prevent accidental intravenous administration of epidural medications, which could cause severe toxicity or seizures.

Delayed respiratory depression due to long drug absorption. Fentanyl's slow transdermal absorption can lead to peak effects hours later, necessitating extended monitoring for insidious onset of respiratory issues.

To deliver patient-initiated analgesic doses safely. PCA pumps enable patients to control their pain relief by administering doses as needed, incorporating safety features like lockouts to prevent overdose.

Fold adhesive sides together and discard per facility policy. Folding seals residual fentanyl inside, minimizing accidental exposure risks during disposal in accordance with controlled substance protocols.